Correction to “A New Paradigm for Precision Drug Delivery in Inflammatory Bowel Disease: Effective Transfer, Enhanced Retention, and Pathology‐Targeting Treatment via Biomaterials and Engineered Platforms”
MedComm – Biomaterials and Applications · 2026-12 · 5 (4)
DOI: 10.1002/mba2.70109 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm – Biomaterials and Applications, online erschienen am 03.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “A New Paradigm for Precision Drug Delivery in Inflammatory Bowel Disease: Effective Transfer, Enhanced Retention, and Pathology‐Targeting Treatment via Biomaterials and Engineered Platforms”. MedComm – Biomaterials and Applications, 5(4). https://doi.org/10.1002/mba2.70109
Vancouver
Correction to “A New Paradigm for Precision Drug Delivery in Inflammatory Bowel Disease: Effective Transfer, Enhanced Retention, and Pathology‐Targeting Treatment via Biomaterials and Engineered Platforms”. MedComm – Biomaterials and Applications. 2026;5(4). doi:10.1002/mba2.70109
BibTeX
@article{euvimed2026,
title = {Correction to “A New Paradigm for Precision Drug Delivery in Inflammatory Bowel Disease: Effective Transfer, Enhanced Retention, and Pathology‐Targeting Treatment via Biomaterials and Engineered Platforms”},
journal = {MedComm – Biomaterials and Applications},
year = {2026},
volume = {5},
number = {4},
doi = {10.1002/mba2.70109}
}
EUVIMED